FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025426657> ?p ?o ?g. }

• W2025426657 endingPage "222" @default.
• W2025426657 startingPage "217" @default.
• W2025426657 abstract "Angiotensin converting enzyme inhibitors (ACE-I) are a mainstay for the treatment of heart failure, and of diabetic microalbuminuria. Recently ACE-I have been found to decrease plasma levels of circulating vascular cell adhesion molecule-1 (cVCAM-1) in patients with congestive heart failure. As increased cVCAM-1 levels are pathognomonic for diabetics with microangiopathy, we investigated the effects of ACE-I on plasma levels of cVCAM-1, intercellular adhesion molecule (cICAM-1), and cE-selectin in microalbuminuric diabetics. In addition, the effects of ACE-I on plasma levels of plasminogen activator inhibitor (PAI-1) and of tissue plasminogen activator (TPA) were studied. Fosinopril (10 mg/day) was administered over 12 weeks to 11 microalbuminuric patients with non-insulin-dependent diabetes mellitus (NIDDM). As expected, baseline plasma concentrations of cE-selectin, cICAM-1, and cVCAM-1 were markedly higher in patients than in healthy control subjects (n = 82; P < .001). PAI-1 levels in NIDDM were similar to those in control subjects, whereas TPA levels were about 25% lower in patients than in control subjects (P = .013). Serum levels of cVCAM-1 decreased by -19% (CI: -25% to -13%) after treatment with fosinopril (P = .003) and were no longer different from those of the control group. In contrast, plasma levels of cE-selectin, cICAM-1, PAI-1, and TPA were unaffected. As expected microalbuminuria decreased by -44% (CI: -65 to -22; P = .004). In conclusion, fosinopril lowered cVCAM-1 levels along with microalbuminuria in NIDDM. This may represent a novel mechanism of action of ACE-I in diabetes-associated endothelial dysfunction. Whether decreased VCAM-1 expression is responsible for the observed reduction in microalbuminuria, deserves further investigation." @default.
• W2025426657 created "2016-06-24" @default.
• W2025426657 creator A5012757803 @default.
• W2025426657 creator A5021231123 @default.
• W2025426657 creator A5029196374 @default.
• W2025426657 creator A5060280199 @default.
• W2025426657 creator A5077182872 @default.
• W2025426657 creator A5080941679 @default.
• W2025426657 creator A5082163795 @default.
• W2025426657 date "1999-02-01" @default.
• W2025426657 modified "2023-10-13" @default.
• W2025426657 title "Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria" @default.
• W2025426657 cites W1410931458 @default.
• W2025426657 cites W1963638588 @default.
• W2025426657 cites W1964962715 @default.
• W2025426657 cites W1968439705 @default.
• W2025426657 cites W1976778785 @default.
• W2025426657 cites W1981594756 @default.
• W2025426657 cites W1981729001 @default.
• W2025426657 cites W1982754616 @default.
• W2025426657 cites W1983338308 @default.
• W2025426657 cites W1988377926 @default.
• W2025426657 cites W1997635642 @default.
• W2025426657 cites W1998152321 @default.
• W2025426657 cites W2001534894 @default.
• W2025426657 cites W2001563453 @default.
• W2025426657 cites W2002565780 @default.
• W2025426657 cites W2002645756 @default.
• W2025426657 cites W2002833122 @default.
• W2025426657 cites W2008009125 @default.
• W2025426657 cites W2010715396 @default.
• W2025426657 cites W2011013456 @default.
• W2025426657 cites W2013710089 @default.
• W2025426657 cites W2016112964 @default.
• W2025426657 cites W2022580763 @default.
• W2025426657 cites W2022898557 @default.
• W2025426657 cites W2027016563 @default.
• W2025426657 cites W2028001963 @default.
• W2025426657 cites W2029487004 @default.
• W2025426657 cites W2036527917 @default.
• W2025426657 cites W2039831544 @default.
• W2025426657 cites W2041956969 @default.
• W2025426657 cites W2044645809 @default.
• W2025426657 cites W2048630527 @default.
• W2025426657 cites W2053572666 @default.
• W2025426657 cites W2055420779 @default.
• W2025426657 cites W2055855948 @default.
• W2025426657 cites W2066809361 @default.
• W2025426657 cites W2069117910 @default.
• W2025426657 cites W2071862675 @default.
• W2025426657 cites W2082045372 @default.
• W2025426657 cites W2086011121 @default.
• W2025426657 cites W2088876606 @default.
• W2025426657 cites W2099211014 @default.
• W2025426657 cites W2101651570 @default.
• W2025426657 cites W2138928713 @default.
• W2025426657 cites W2142682755 @default.
• W2025426657 cites W2398673162 @default.
• W2025426657 cites W2410467940 @default.
• W2025426657 cites W2466932343 @default.
• W2025426657 doi "https://doi.org/10.1016/s0895-7061(98)00229-5" @default.
• W2025426657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10090351" @default.
• W2025426657 hasPublicationYear "1999" @default.
• W2025426657 type Work @default.
• W2025426657 sameAs 2025426657 @default.
• W2025426657 citedByCount "49" @default.
• W2025426657 countsByYear W20254266572012 @default.
• W2025426657 countsByYear W20254266572013 @default.
• W2025426657 countsByYear W20254266572019 @default.
• W2025426657 countsByYear W20254266572021 @default.
• W2025426657 crossrefType "journal-article" @default.
• W2025426657 hasAuthorship W2025426657A5012757803 @default.
• W2025426657 hasAuthorship W2025426657A5021231123 @default.
• W2025426657 hasAuthorship W2025426657A5029196374 @default.
• W2025426657 hasAuthorship W2025426657A5060280199 @default.
• W2025426657 hasAuthorship W2025426657A5077182872 @default.
• W2025426657 hasAuthorship W2025426657A5080941679 @default.
• W2025426657 hasAuthorship W2025426657A5082163795 @default.
• W2025426657 hasBestOaLocation W20254266571 @default.
• W2025426657 hasConcept C126322002 @default.
• W2025426657 hasConcept C134018914 @default.
• W2025426657 hasConcept C27016395 @default.
• W2025426657 hasConcept C2779611605 @default.
• W2025426657 hasConcept C2779679481 @default.
• W2025426657 hasConcept C2780189551 @default.
• W2025426657 hasConcept C2780436477 @default.
• W2025426657 hasConcept C2780675426 @default.
• W2025426657 hasConcept C2781203188 @default.
• W2025426657 hasConcept C519581460 @default.
• W2025426657 hasConcept C555293320 @default.
• W2025426657 hasConcept C71924100 @default.
• W2025426657 hasConcept C84393581 @default.
• W2025426657 hasConceptScore W2025426657C126322002 @default.
• W2025426657 hasConceptScore W2025426657C134018914 @default.
• W2025426657 hasConceptScore W2025426657C27016395 @default.
• W2025426657 hasConceptScore W2025426657C2779611605 @default.
• W2025426657 hasConceptScore W2025426657C2779679481 @default.
• W2025426657 hasConceptScore W2025426657C2780189551 @default.

• next